Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The report provides an in-depth analysis of the leading companies operating in the Glucagon-like peptide-1 agonists market
All studies adopted the model-based simulation approach using data predominately derived from clinical trials, except for our study, which employed a trial/study-based analysis approach using real-world effectiveness and cost data, to conduct CEA
Walker, E
doi: 10.3389/fphar.2026.1856307 Received 15 April 2026 Revised 25 May 2026 Accepted 27 May 2026 Published 17 June 2026 Volume 17 - 2026 Edited by Carlos Rodrguez-Nogales, Universidad Complutense de Madrid, Spain Reviewed by Madhusudan Prasad Singh, All India Institute of Medical Sciences, Deoghar (AIIMS Deoghar), India Alessandro Conforti, Nephrology Unit, ASL Roma 4, Italy Updates Copyright 2026 Wu, Lei, Sa, Zhong and Lu
US$ 23.74
US$ 22.65
US$ 24.08
US$ 28.15
US$ 29.18
